Delayed gastric emptying and gastroparesis are significant gastrointestinal manifestations in patients with Parkinson’s disease (PD), occurring as part of the broader spectrum of autonomic dysfunction. Delayed gastric emptying is highly prevalent in PD and can occur at any stage of the disease. our case suggests that subcutaneous fos- levodopa may represent a feasible therapeutic approach in patients with severely impaired gastrointestinal absorption and motor fluctuations.

Parkinsonism-hyperpyrexia syndrome due to gastroparesis treated with subcutaneous foslevodopa: a case report

Artusi, C. A.;
2025-01-01

Abstract

Delayed gastric emptying and gastroparesis are significant gastrointestinal manifestations in patients with Parkinson’s disease (PD), occurring as part of the broader spectrum of autonomic dysfunction. Delayed gastric emptying is highly prevalent in PD and can occur at any stage of the disease. our case suggests that subcutaneous fos- levodopa may represent a feasible therapeutic approach in patients with severely impaired gastrointestinal absorption and motor fluctuations.
2025
Parkinsonism‐hyperpyrexia syndrome; Parkinson's disease; foslevodopa
File in questo prodotto:
File Dimensione Formato  
Parkinsonism-hyperpyrexia syndrome due to gastroparesis treated with subcutaneous foslevodopa - case rep.pdf

solo utenti autorizzati

Tipologia: Versione dell'editore
Licenza: Accesso ristretto
Dimensione 446.79 kB
Formato Adobe PDF
446.79 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11562/1181387
Citazioni
  • ???jsp.display-item.citation.pmc??? 1
  • Scopus 1
  • ???jsp.display-item.citation.isi??? 1
social impact